Skip to main content
Caplight Logo









Carcell Biopharma

Carcell Biopharma

Private
SingaporeHealthcare & Life Scienceshttps://carcell.com

Last Round

Seed

Nov 1, 2021

Company Overview

Carcell Biopharma operates in Healthcare & Life Sciences and is based in Singapore. Its latest recorded funding round was a Seed round in November 2021.

Carcell Biopharma is a healthcare company that develops biopharmaceutical platforms intended to promote next-generation cell and gene therapies, focusing on engineered red blood cells and non-viral gene delivery.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Carcell Biopharma Comparables

Compare Carcell Biopharma with similar companies based on industry and business-model similarity.

Carcell Biopharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Carmine Therapeutics
86%
Scarlet Therapeutics
84%
Anokion
59%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Carcell Biopharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 1, 2021
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Carcell Biopharma Investors

Notable investors and investment history

Carcell Biopharma investors
InvestorRounds
BioTrack CapitalSeed
EVX VenturesSeed
Hyfinity InvestmentsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 2, 2026

    Monthly visitors increased 68% MoM.

  • Jan 2, 2026

    Monthly visitors grew 31% MoM, reaching 783.

Book a demo to see all signals

For institutional investors. Book with your work email.

Carcell Biopharma Filings

Explore SEC and related filing metadata, where available.

Carcell Biopharma filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Carcell Biopharma's valuation, stock price, and market status.

Is Carcell Biopharma a public or private company?

Carcell Biopharma is a private company.

What is the current stock price of Carcell Biopharma?

Carcell Biopharma is a private company, so its shares have no public market price. Caplight tracks Carcell Biopharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Carcell Biopharma worth (valuation)?

Valuation information for Carcell Biopharma is not publicly available.

Can I buy Carcell Biopharma stock?

Carcell Biopharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Carcell Biopharma's last funding round?

Carcell Biopharma's most recent funding round was Seed on November 1, 2021.

Who are the main investors in Carcell Biopharma?

Key investors in Carcell Biopharma include Hyfinity Investments.

Will Carcell Biopharma IPO soon?

No public IPO plans have been announced for Carcell Biopharma.

How can I track Carcell Biopharma secondary market activity?

Caplight tracks bids, offers, and trades in Carcell Biopharma's shares on secondary markets.

Firmographic Details

HeadquartersSingapore
Employee Range5
Year Founded2021
Last FundingNov 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?